SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
LB Pharma landed on the Nasdaq Thursday, with 3 million additional shares sold than expected.
September 11, 2025
 · 
2 min read
 · 
Annalee Armstrong
U.S. and Chinese flags in concrete, broken in the middle
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
A draft executive order obtained by The New York Times purports to clamp down on the pharmaceutical industry’s ability to buy new molecules from biotechs based in China, along with a number of other proposed reforms.
September 11, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Hiring collage showing HR checking applicant information
Job Trends
Hiring Outlook: Fewer Job Openings, High Competition Await Biopharma Job Seekers
The biopharma job market remains challenging, based on BioSpace data. In August, job postings live on the website dropped 32% year over year. In addition, during the first eight months of 2025, over 26,000 people were laid off or projected to be laid off.
September 11, 2025
 · 
4 min read
 · 
Angela Gabriel
Photo of skyline of downtown New York, Brooklyn Bridge and Manhattan
Business
New York City’s Life Sciences Scene Grows in Stature
New York City has seen increased life sciences employment during the past decade as public funding and key projects like JLABS @ NYC have given the area a boost. A Partnership Fund for New York City executive discusses the city’s strengths and a notable challenge facing businesses.
September 11, 2025
 · 
5 min read
 · 
Angela Gabriel
Focal seizure. Vector illustration of human brain and electroencephalograhy or EEG originating from temporal lobe.
Gene therapy
Capsida Reports Patient Death in Gene Therapy Trial
Capsida has yet to disclose the exact cause of death. The patient had received the gene therapy CAP-002 for a type of epilepsy.
September 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Joint pain anatomy medical concept
Pain
FDA Looks To Streamline Development of Non-Opioid Painkillers
New draft guidelines suggest the FDA is open to exercising regulatory flexibility for non-opioid drugs being developed for chronic pain.
September 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Goal concept. Human hand in dotted pop art style pointing on the target for red paper plane. Vector illustration
Duchenne muscular dystrophy
Avidity Touts Functional Improvements for DMD Therapy, Clearing Way to FDA
Analysts at BMO Capital Markets expect the lack of other exon-44-skiping therapies to facilitate a “smooth” approval process for Avidity’s del-zota.
September 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.
September 11, 2025
 · 
1 min read
 · 
Tristan Manalac
THOUGHT LEADERSHIP
Webinar: Driving Biopharma Engagement: How Thought Leadership and Marketing Fuel Lead Generation
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. This webinar will show leaders how strategic insights and targeted outreach can turn awareness into high-converting leads. Watch now.
September 10, 2025
 · 
1 min read
 · 
BioSpace Insights
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS